erythrosine has been researched along with Diabetic Glomerulosclerosis in 9 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hippurate, a ligand that accumulates in renal failure, did alter fluorescein binding in a defatted albumin solution but not sufficiently to account for the differences in TCFERs." | 1.29 | Plasma fluorescein binding and transcapillary fluorescein escape rate in renal failure associated with diabetes. ( Ahlfors, CE; Alley, PA; Bry, WI; Cheung, AT; Cox, KL, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, T | 1 |
| Wang, S | 1 |
| Zhang, X | 1 |
| Zai, W | 1 |
| Fan, J | 1 |
| Chen, W | 1 |
| Bian, Q | 1 |
| Luan, J | 1 |
| Shen, Y | 1 |
| Zhang, Y | 1 |
| Ju, D | 1 |
| Mei, X | 1 |
| Molitoris, BA | 1 |
| FARRANT, PC | 1 |
| SHEDDEN, WI | 1 |
| Ahlfors, CE | 1 |
| Alley, PA | 1 |
| Bry, WI | 1 |
| Cheung, AT | 1 |
| Cox, KL | 1 |
| Larsen, M | 3 |
| Hommel, E | 3 |
| Parving, HH | 2 |
| Lund-Andersen, H | 3 |
| Loft, S | 1 |
| Bartos, V | 1 |
| Kolc, J | 1 |
| Nozicková, M | 1 |
| Málek, P | 1 |
| Kwaan, HC | 1 |
| Colwell, JA | 1 |
| Cruz, S | 1 |
| Suwanwela, N | 1 |
| Dobbie, JG | 1 |
1 review available for erythrosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Rethinking CKD Evaluation: Should We Be Quantifying Basal or Stimulated GFR to Maximize Precision and Sensitivity?
Topics: Animals; Biomarkers; Creatinine; Diabetic Nephropathies; Dietary Proteins; Disease Progression; Earl | 2017 |
1 trial available for erythrosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
Topics: Adult; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; D | 1990 |
7 other studies available for erythrosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
Topics: Albuminuria; Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High | 2018 |
OBSERVATIONS ON THE UPTAKE OF INSULIN CONJUGATED WITH FLUORESCEIN ISOTHIOCYANATE BY DIABETIC KIDNEY TISSUE.
Topics: Diabetes Mellitus; Diabetic Nephropathies; Fluorescein; Fluoresceins; Geriatrics; Histocytochemistry | 1965 |
Plasma fluorescein binding and transcapillary fluorescein escape rate in renal failure associated with diabetes.
Topics: Adult; Capillaries; Diabetic Nephropathies; Female; Fluorescein; Fluoresceins; Humans; Male; Middle | 1995 |
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Capto | 1989 |
Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein.
Topics: Adult; Blood-Retinal Barrier; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabe | 1988 |
Indications and experimental preparatory studies for pancreas transplantation.
Topics: Animals; Coumarins; Diabetic Angiopathies; Diabetic Nephropathies; Dogs; Drug Combinations; Fluoresc | 1985 |
Increased platelet aggregation in diabetes mellitus.
Topics: Adenosine Diphosphate; Aspirin; Blood Chemical Analysis; Blood Proteins; Creatinine; Diabetes Mellit | 1972 |